Edwards’ heart-valve delivery patent revoked by EPO after Meril challenge
MLex Summary: Edwards Lifesciences' patent on a catheter-based heart-valve delivery system has been revoked by the European Patent Office, after Meril GmbH challenged it. The EPO's Boards of Appeal found that the...To view the full article, register now.
Already a subscriber? Click here to view full article